Cargando…
A retrospective observational research study to describe the real‐world use of bosutinib in patients with chronic myeloid leukemia in the United Kingdom and the Netherlands
OBJECTIVES: To describe the real‐world effectiveness and safety of bosutinib in patients with chronic myeloid leukemia (CML). METHODS: This was a multi‐center, retrospective, non‐interventional chart review study conducted in 10 hospitals in the United Kingdom and the Netherlands. RESULTS: Eighty‐se...
Autores principales: | Claudiani, Simone, Janssen, Jeroen J. W. M., Byrne, Jenny, Smith, Graeme, Blijlevens, Nicole, Raghavan, Manoj, Smith, Matthew, Clark, Richard E., Mclain‐Smith, Susan, Carter, Angela M., Milojkovic, Dragana, Apperley, Jane F. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9321569/ https://www.ncbi.nlm.nih.gov/pubmed/35403752 http://dx.doi.org/10.1111/ejh.13775 |
Ejemplares similares
-
Prevalence of Sars-Cov-2 Infection in Patients with Chronic Myeloid Leukemia
por: Claudiani, Simone, et al.
Publicado: (2020) -
Bosutinib for Chronic Myeloid Leukemia
por: Breccia, Massimo, et al.
Publicado: (2015) -
FISH-negative BCR::ABL1-positive e19a2 chronic myeloid leukaemia: the most cryptic of insertions
por: May, Philippa C., et al.
Publicado: (2023) -
MR4 sustained for 12 months is associated with stable deep molecular responses in chronic myeloid leukemia
por: Claudiani, Simone, et al.
Publicado: (2019) -
PB1966: THE EFFECT OF BODY MASS INDEX ON THE SAFETY OF BOSUTINIB IN PATIENTS WITH CHRONIC MYELOID LEUKEMIA: A POST HOC POOLED DATA ANALYSIS
por: Isfort, Susanne, et al.
Publicado: (2023)